Skip to main content
Top
Published in: Nuclear Medicine and Molecular Imaging 4/2015

01-12-2015 | Case Report

Malignant Peritoneal Mesothelioma Masquerades as Peritoneal Metastasis on 18F-FDG PET/CT Scans; a Rare Diagnosis that Should Not Be Missed

Authors: Apichaya Claimon, Ji-In Bang, Gi Jeong Cheon, Euishin Edmund Kim, Dong Soo Lee

Published in: Nuclear Medicine and Molecular Imaging | Issue 4/2015

Login to get access

Abstract

Malignant peritoneal mesothelioma (MPM) is a rare but fatal tumor. The clinical presentations and imaging findings are nonspecific and resemble various diseases, including peritoneal metastasis. Imaging findings of MPH on 18F-18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) are diverse and not well described. We report the two cases of biopsy-proven MPH using 18F-FDG PET/CT. In our cases, interesting disease patterns—including MPH arising from visceral peritoneal lining of kidney that suffer from polycystic disease and from the parietal peritoneum beneath the appendectomy scar—were presented. One case showed classical metastases localized within the abdominal cavity; while the other case exhibited the rare pattern of extensive multi-organ metastases. By knowing the possible variations and diagnostic pitfalls of 18F-FDG PET/CT findings in MPM, more accurate interpretation of such mysterious cancer is attainable.
Literature
2.
go back to reference Ahmed I, Ahmed Tipu S, Ishtiaq S. Malignant mesothelioma. PJPS. 2013;29:1433–8. Ahmed I, Ahmed Tipu S, Ishtiaq S. Malignant mesothelioma. PJPS. 2013;29:1433–8.
3.
go back to reference Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983;1:386–91.PubMed Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983;1:386–91.PubMed
4.
5.
go back to reference Vilardell AD, Rasiej MJ, Taub RN, Ichise M. Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma. Q J Nucl Med Mol Imaging. 2014 Vilardell AD, Rasiej MJ, Taub RN, Ichise M. Clinical utility of 18F-FDG positron emission tomography in malignant peritoneal mesothelioma. Q J Nucl Med Mol Imaging. 2014
6.
go back to reference Ozguven S, Aras M, Dede F, Ones T, Turoglu HT. Scrotal peritoneal mesothelioma on PET/CT. Clin Nucl Med. 2014;39:1045–6.CrossRefPubMed Ozguven S, Aras M, Dede F, Ones T, Turoglu HT. Scrotal peritoneal mesothelioma on PET/CT. Clin Nucl Med. 2014;39:1045–6.CrossRefPubMed
7.
go back to reference Le BB, Nguyen BD. Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging. Clin Nucl Med. 2015;40:e68–70.CrossRefPubMed Le BB, Nguyen BD. Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging. Clin Nucl Med. 2015;40:e68–70.CrossRefPubMed
8.
go back to reference Abikhzer G, Gourevich K, Arkovitz M, Postovsky S, Keidar Z. Role of 18F-FDG PET/CT in the staging of pediatric peritoneal mesothelioma. Clin Nucl Med. 2013;38:e331–2.CrossRefPubMed Abikhzer G, Gourevich K, Arkovitz M, Postovsky S, Keidar Z. Role of 18F-FDG PET/CT in the staging of pediatric peritoneal mesothelioma. Clin Nucl Med. 2013;38:e331–2.CrossRefPubMed
9.
go back to reference Cao Q, Lu M, Heath J, Hausner PF, Alexander HR, Dilsizian V, et al. 18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Clin Nucl Med. 2012;37:492–4.CrossRefPubMed Cao Q, Lu M, Heath J, Hausner PF, Alexander HR, Dilsizian V, et al. 18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Clin Nucl Med. 2012;37:492–4.CrossRefPubMed
10.
go back to reference Allen TC, Cagle PT, Churg AM, Colby TV, Gibbs AR, Hammar SP, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29:866–73.CrossRefPubMed Allen TC, Cagle PT, Churg AM, Colby TV, Gibbs AR, Hammar SP, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29:866–73.CrossRefPubMed
11.
go back to reference Sheffield BS, Tinker AV, Shen Y, Hwang H, Li-Chang HH, Pleasance E, et al. Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. PLoS One. 2015;10, e0119689.PubMedCentralCrossRefPubMed Sheffield BS, Tinker AV, Shen Y, Hwang H, Li-Chang HH, Pleasance E, et al. Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. PLoS One. 2015;10, e0119689.PubMedCentralCrossRefPubMed
12.
go back to reference Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, Ortega-Perez G, Stuart OA, Marchettini P, et al. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol. 2002;29:51–61.CrossRefPubMed Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, Ortega-Perez G, Stuart OA, Marchettini P, et al. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol. 2002;29:51–61.CrossRefPubMed
Metadata
Title
Malignant Peritoneal Mesothelioma Masquerades as Peritoneal Metastasis on 18F-FDG PET/CT Scans; a Rare Diagnosis that Should Not Be Missed
Authors
Apichaya Claimon
Ji-In Bang
Gi Jeong Cheon
Euishin Edmund Kim
Dong Soo Lee
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 4/2015
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-015-0360-2

Other articles of this Issue 4/2015

Nuclear Medicine and Molecular Imaging 4/2015 Go to the issue